What is new in the management of coeliac disease?
European Journal of Internal Medicine · 2025-04 · 134 · 1-8
DOI: 10.1016/j.ejim.2025.01.028 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Internal Medicine, 2025-04. Verfasst von Mohamed G Shiha und 1 weiteren Autor:innen. Beteiligte Einrichtung: Academic Unit of Gastroenterology, Sheffield Teaching Hospitals, Sheffield, UK; Division of Clinical Medicine, School of Medicine and Population Heal…. Hauptthemen laut MEDLINE: Celiac Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 88 Literaturangaben.
Abstract (Originalsprache)
Coeliac disease is the most common immune-mediated enteropathy, affecting approximately 1 % of the population worldwide. Currently, the vast majority of individuals remain undiagnosed. Coeliac disease is triggered by gluten ingestion in genetically predisposed individuals carrying the human leukocyte antigen (HLA) genes; HLA-DQ2 and HLA-DQ8. Patients with coeliac disease present with a wide spectrum of gastrointestinal and extraintestinal manifestations and, in some cases, without any symptoms. The diagnosis of coeliac disease in adults is based on a combination of clinical suspicion, positive serological markers and histological evidence of small intestinal atrophy on duodenal biopsies. The only effective treatment is a strict, lifelong gluten-free diet. However, up to 20 % of patients report persistent or recurrent symptoms. In this review, we provide a comprehensive update on coeliac disease, focusing on its relevance to the different medical specialities and highlighting the need for a multidisciplinary approach to its diagnosis and management. Clinicians practicing internal medicine have a unique opportunity to diagnose this multisystem autoimmune disease. By doing so, they would avoid delays in diagnosis for these patients. A low threshold for serological testing is recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Academic Unit of Gastroenterology, Sheffield Teaching Hospitals, Sheffield, UK; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. Electronic address: Mohame…
- Academic Unit of Gastroenterology, Sheffield Teaching Hospitals, Sheffield, UK; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
Zitieren
APA
Shiha, M. G., & Sanders, D. S. (2025). What is new in the management of coeliac disease?. European Journal of Internal Medicine, 134, 1-8. https://doi.org/10.1016/j.ejim.2025.01.028
Vancouver
Shiha MG, Sanders DS. What is new in the management of coeliac disease?. European Journal of Internal Medicine. 2025;134:1-8. doi:10.1016/j.ejim.2025.01.028
BibTeX
@article{Shiha2025,
author = {Shiha, Mohamed G and Sanders, David S},
title = {What is new in the management of coeliac disease?},
journal = {European Journal of Internal Medicine},
year = {2025},
volume = {134},
pages = {1--8},
doi = {10.1016/j.ejim.2025.01.028}
}
EUVIMED